All links provided below will direct you to the respective resource on the FDA website.
“Advanced Topics: Successful Development of Quality Cell and Gene Therapy Products”
Guidance for Industry Clinical Considerations for Therapeutic Cancer Vaccines – October 2011
Guidance for Industry S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals – July 1997
Guidance for Industry S6 Addendum Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals – May 2012
Back to Top
FDA webpage summarizing 4 programs
Guidance for Industry Expedited Programs for Serious Conditions – Drugs and Biologics – May 2014